Elevian
PrivateLast Round
Series A
Sep 16, 2021
Total Funding Raised
$60.5M
Company Overview
Elevian is a biotechnology company that develops regenerative medicines aimed at halting and reversing the molecular damage associated with aging by targeting its root causes and enhancing the body's natural repair and regeneration processes to prevent and treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elevian Comps
Public and private peers based on sector, stage, and business model.
Elevian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2021 | ||||
| Seed | Nov 24, 2020 | ||||
| Seed | Sep 6, 2018 |
Elevian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| For Good Ventures | Seed |
| StartX | Seed |
| ArteFin GmbH | Seed |
| Kizoo Technology Capital | Seed |
| Stanford-StartX Fund | Seed |
| Longevity Fund | Seed |
| BOLD Capital Partners | Seed, Series A |
Elevian Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elevian's valuation, stock price, and market status.
